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Abstract. 
 
The netrins are a family of laminin-related
molecules. Here, we characterize a new member of the
 
family, 
 
b
 
-netrin. 
 
b
 
-Netrin is homologous to the NH
 
2
 
terminus of laminin chain short arms; it contains a lami-
nin-like domain VI and 3.5 laminin EGF repeats and a
netrin C domain. Unlike other netrins, this new netrin
 
is more related to the laminin 
 
b
 
 chains, thus, its name
 
b
 
-netrin. An initial analysis of the tissue distribution re-
vealed that kidney, heart, ovary, retina, and the olfac-
tory bulb were tissues of high expression. We have ex-
pressed the molecule in a eukaryotic cell expression
system and made antibodies to the expressed product.
Both in situ hybridization and immunohistochemistry
were used to describe the cellular source of 
 
b
 
-netrin
and where 
 
b
 
-netrin is deposited. 
 
b
 
-Netrin is a basement
membrane component; it is present in the basement
membranes of the vasculature, kidney, and ovaries. In
addition, 
 
b
 
-netrin is expressed in a limited set of ﬁber
tracts within the brain, including the lateral olfactory
tract and the vomeronasal nerve. Functional studies
were performed and show that 
 
b
 
-netrin promotes neu-
rite elongation from olfactory bulb explants. Together,
these data suggest that 
 
b
 
-netrin is important in neural,
kidney, and vascular development.
Key words: axon guidance • kidney • olfactory bulb • 
vasculature • brain
 
Introduction
 
Netrins comprise a family of structurally related secreted
molecules involved in axon guidance. Axons sense netrins
as either attractants or repellents, depending upon which
netrin receptors are expressed on their growth cones
(Hedgecock et al., 1990; Serafini et al., 1994; Colamarino
and Tessier-Lavigne, 1995; Winberg et al., 1998) or dif-
ferences in the cellular signal transduction machinery
(Bashaw and Goodman, 1999).
To date, several netrins have been described. A single
 
netrin, UNC-6, has been identified in
 
 Caenorhabditis ele-
gans
 
 (Ishii et al., 1992) and two have been described in
 
Drosophila
 
, Netrin-A and Netrin-B (Harris et al., 1996;
Mitchell et al., 1996). Three netrins have been identified in
vertebrates: netrin-1 has been identified in chicken (Se-
rafini et al., 1994), mouse (Serafini et al., 1996), 
 
Xenopus
 
(de la Torre et al., 1997), zebrafish (Lauderdale et al., 1997;
Strahle et al., 1997), and humans (Meyerhardt et al., 1999);
netrin-2 in chickens (Serafini et al., 1994); and netrin-3 in
humans (NTN2L; Van Raay et al., 1997) and mouse (Wang
et al., 1999). Netrins 1, 2, and 3 are all structurally related
to the short arms of laminin 
 
g
 
 chains, and contain a laminin
VI domain and three EGFlike repeats similar to the lami-
nin V domain (V-1, V-2, and V-3); they also contain a posi-
tively charged heparin-binding COOH-terminal domain
termed domain C (Serafini et al., 1994; Keino-Masu et al.,
1996).
Mutations in the netrin genes in 
 
C. elegans
 
 (
 
unc-6)
 
(Hedgecock et al., 1990), 
 
Drosophila 
 
(NetA/B) (Winberg
et al., 1998), and mouse (netrin-1) (Skarnes et al., 1995; Se-
rafini et al., 1996) produce defects in axon guidance affect-
ing circumferential and commissural growth. Studies in
vitro show that netrin-1 can act from a distance within a
collagen gel to cause the outgrowth of spinal cord axons,
implicating chemoattraction as one of the mechanisms of
action of netrins (Kennedy et al., 1994).
In the mouse and chicken, the RNA transcripts encoding
the netrins are widely distributed throughout the organism
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(Wang et al., 1999). Netrin RNAs are prominent in embry-
onic muscle and the bronchi of lung; transcripts are also
present in the condensing mesenchyme of the limb and
esophagus. However, netrin RNA location has been most
extensively documented in the central nervous system
(CNS)
 
1
 
: netrin-1 is strongly expressed in the developing
spinal cord, in the floorplate, and the ventral ventricular
zone (Serafini et al., 1996; Puschel, 1999; Wang et al., 1999);
netrin-2 is expressed throughout the spinal cord and in the
dorsal root ganglia, but not in the floorplate (Wang et al.,
1999); and netrin-3 is expressed in sensory (dorsal root and
cranial) ganglia (Puschel, 1999; Wang et al., 1999).
The effect of netrins upon axon extension in vitro, to-
gether with the tightly restricted regional expression of ne-
trin RNAs within targets of axon outgrowth, support the
generally held hypothesis that netrins act as diffusible at-
tractants or repellents for responsive axons. However, lo-
calization of netrin-1 protein in the chicken brain, retina,
and spinal cord appear to contradict this concept (MacLen-
nan et al., 1997). For example, in the spinal cord, although
netrin-1 RNA is localized where the commissural fibers
cross in the floorplate, netrin-1 protein is not concentrated
within the floorplate. Rather, netrin-1 protein is deposited
in or near the basement membrane of the spinal cord. Sim-
ilarly, Netrin-A and Netrin-B proteins are localized at the
 
Drosophila
 
 midline in a manner analogous to that in the
chicken spinal cord (Harris et al., 1996). The ability of the ne-
trins to bind heparin through the C domain (Serafini et al.,
1994; Keino-Masu et al., 1996) is consistent with a hapto-
tactic function for netrins (MacLennan et al., 1997), as this
binding suggests that netrins may be immobilized in tissues,
either to cell surfaces or to components of the extracellular
matrix. Here, we describe another member of the netrin
family in humans and mice. Netrins-1, 2, and 3, while con-
taining some laminin 
 
b
 
 chain–like features (Ishii et al.,
1992; Wadsworth et al., 1996), are more closely related to
the laminin 
 
g
 
 chains than to other laminin chains. In con-
trast, the novel netrin, described here, is more closely re-
lated to laminin 
 
b
 
 chains than to other laminin short arms.
Hence, we have termed this molecule 
 
b
 
-netrin.
 
Materials and Methods
 
cDNA Isolation
 
Comparison of the laminin 
 
b
 
2 chain amino acid sequence (SWISS-PROT
accession number NP_002283) with the dbEST database (Boguski, et al.,
1993; National Center for Biotechnology Information) using the program
BLAST (Altschul et al., 1990) yielded one clone (EMBL/Genbank/DDBJ
accession number Z50158) as a possible candidate for a novel laminin
chain. Specific primers for 5
 
9
 
 or 3
 
9
 
 extensions were deduced from that
expressed sequence tag, and nested PCRs were performed on skeletal
muscle cDNA or human placental cDNA to extend the clone using Mara-
thon-Ready cDNA (CLONTECH Laboratories, Inc.) following the man-
ufacturer’s instructions. For PCR, the Long Expand PCR Kit (Boehringer
Mannheim) was used with the following conditions: denaturation, 94
 
8
 
C
for 3 min; 10 cycles of 94
 
8
 
C for 30 s, 63
 
8
 
C (
 
2
 
0.5
 
8
 
C per cycle) for 30 s, and
68
 
8
 
C for 4 min; 25 cycles of 94
 
8
 
C for 30 s, 58
 
8
 
C for 30 s, and 68
 
8
 
C for 4 min
(
 
1
 
10 s per cycle); and a final extension period at 68
 
8
 
C of 8 min.
The PCR samples from the first round were purified (PCR purification
kit; QIAGEN) and 2% of the sample volume was used in the second
round of PCR using the PCR protocol given above. These PCR products
were purified from an agarose gel (gel purification kit™; QIAGEN) and
 
either subcloned (into PCR II or PCR 2.1 vectors; Invitrogen) or directly
used for sequencing. To confirm the nucleotide sequence and control for
PCR-induced nucleotide substitutions, gene-specific primers were used to
re-amplify the entire cDNA. A first strand cDNA synthesis kit (CLON-
TECH Laboratories, Inc.) was used to synthesize cDNA from total spleen
RNA using oligo dT or random primers following the manufacturer’s pro-
tocol; PCR was used to generate overlapping clones complementary to the
entire human 
 
b
 
-netrin. Sequencing of all the PCR products obtained from
the cDNA confirmed the nucleotide sequence of the human 
 
b
 
-netrin.
To clone the mouse 
 
b
 
-netrin, nested PCR was performed on reverse-
transcribed embryonic day 15.5 (E15.5) mouse RNA using, for the first
PCR round, the primers Fv1 (5
 
9
 
-dCTGAAACGACAGTCTTGTC-
CCTG-3
 
9
 
) and Rv1 (5
 
9
 
-dTAATGTCTGTTCCTTACTTCGCA-3
 
9
 
), and,
for the second PCR round, nested primers Nfv2 (5
 
9
 
-dCATTGT-
CAAGGGCAGCTGCTTCTG-3
 
9
 
) and NRv2 (5
 
9
 
-dGCCACCCCAG-
GCTTGCAAGGGCA-3
 
9
 
). The PCR conditions were as follows: 1 U 
 
Taq
 
polymerase (Fisher Scientific); denaturation, 94
 
8
 
C for 3 min; 10 cycles of
94
 
8
 
C for 30 s, 50
 
8
 
C (
 
2
 
0.5
 
8
 
C per cycle) for 30 s, and 72
 
8
 
C for 1 min; 25 cy-
cles of 94
 
8
 
C for 30 s, 60
 
8
 
C for 30 s, and 72
 
8
 
C for 1 min; and a final exten-
sion period at 72
 
8
 
C of 5 min. The 500-bp PCR product was purified on an
agarose gel and directly sequenced. The sequence information was used to
generate primers that were used in nested PCR using embryonic day 17
(E17) mouse cDNA (Marathon-Ready) to elongate the 3
 
9
 
 and 5
 
9
 
 ends of
the mouse 
 
b
 
-netrin cDNA.
To generate a genetic relationship map of the netrins and laminins, the
NH
 
2
 
 termini of protein sequences were analyzed with the GrowTree pro-
gram (SeqWeb; Genetics Computer Group Inc.); the following laminin
and netrin protein sequences were used: netrin-1 (AF128865); netrin 3
(AF128866); laminin 
 
a
 
1 chain (J04064); laminin 
 
a
 
2 chain (MMU12147);
laminin 
 
b
 
1 chain (M15525); laminin 
 
b
 
2 chain (AH006792); laminin 
 
b
 
3
chain (U43298); laminin 
 
g
 
1 chain (J03484); and laminin 
 
g
 
3 chain
(AF079520). Protein sequence starting from the VI domain through the
three laminin-EGF modules in domain V were analyzed. The Jukes-Can-
tor method was chosen to correct the distances for multiple substitutions
at a single site; the tree was created with the unweighted pair group
method using arithmetic averages (UPGMA) algorithm.
 
Nucleotide Sequencing
 
Nucleotide sequences were determined with a Thermo Sequenase cycle
sequencing kit and 
 
33
 
P-ddNTPs (Amersham Pharmacia Biotech) using ei-
ther M13 forward or reverse primers or gene-specific primers synthesized
in our laboratory. A 1.5:1 ratio of inosine to guanosine was included in the
sequencing mix. Sequence data were assembled and manipulated using
Genetyx-Max 8.0 and Genestream-1 at http://www2.igh.cnrs.fr/ (Software
Development Co., Ltd.). The signal peptide cleavage site was predicted
using: http://genome.cbs.dtu.dk/services/SignalP/ (Nielsen et al., 1997).
 
Northern and Dot Blot Analyses
 
A 1.7-kbp PCR product
 
 
 
(nucleotides 1,114–2,946)
 
 
 
was labeled with 
 
33
 
P-
dCTP (NEN Life Science Products) using the 
 
redi
 
prime DNA labeling
system (Amersham Pharmacia Biotech). Northern and dot blots (CLON-
TECH Laboratories, Inc.) were prehybridized in 50% formamide, 5
 
3
 
SSPE, 1
 
3
 
 Denhardt’s, 1% SDS, 10% dextran-sulfate, and 0.1 mg/ml
salmon sperm DNA (GIBCO BRL) at 42
 
8
 
C for 2 h. Without further puri-
fication, the probe was denatured in the same buffer plus 1/10 vol/vol hu-
man Cot-1 DNA (Boehringer Mannheim), and 1/10 vol/vol sheared
salmon testis DNA (GIBCO BRL) at 94
 
8
 
C for 5 min, placed on ice, added
to the blots, and was hybridized for 20 h. Blots were washed three times in
2
 
3
 
 SSC, 1% SDS at 42
 
8
 
C and two times in 0.1
 
3
 
 SSC, 1% SDS at 42
 
8
 
C.
Blots were placed on BioMax MR film with a BioMax TranScreen-LE in-
tensifying screen (both from Eastman Kodak Co.) for 20 h at 
 
2
 
70
 
8
 
C.
 
Reverse Transcriptase–PCR (RT-PCR) on Tissue RNA
 
RNA was isolated from animal tissues using the RNeasy kit (QIAGEN),
and cDNA was reverse-transcribed using an RT-PCR kit (CLONTECH)
from the isolated RNA. PCR was performed on these cDNAs using a long
expand PCR kit (Boehringer Mannheim) with GAPDH primers (forward:
5
 
9
 
-pTGAAGGTCGGTGTGAACGGA-3
 
9
 
; reverse: 5
 
9
 
-dGATGGCATG-
GACTGTGGTCA-3
 
9
 
) and the amount of template was normalized for
each tissue. A range of cycle numbers was tested to ensure the amounts
were normalized in the linear range of the reaction. With the gene-specific
primers (forward: 5
 
9
 
-dGTAAGCCCGGTTTCTACCGCGACC-3
 
9
 
; re-
verse: 5
 
9
 
-dCCCTTGTGTGCTTAAGACCTTCAG-3
 
9
 
), another PCR was
performed with the normalized cDNA templates using the following con-
 
1
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ditions: denaturation, 2 min; 94
 
8
 
C, 10 cycles of 94
 
8
 
C for 30 s, 65
 
8
 
C (
 
2
 
0.5
 
8
 
C
per cycle) for 30 s, and 68
 
8
 
C for 2 min; 22 cycles of 94
 
8
 
C for 30 s, 60
 
8
 
C for
30 s, and 68
 
8
 
C for 2 min (
 
1
 
10 s per cycle); and a final extension period at
68
 
8
 
C for 5 min. A pair of gene-specific primers was selected from four
pairs, which were each tested on the cDNAs for optimal amplification/cy-
cle number. PCR products were confirmed by sequencing.
 
Recombinant Expression of Secreted Proteins
 
The following fragments of laminin chain cDNAs were amplified by PCR
and subcloned into an episomal expression vector: human laminin 
 
g
 
2
short arm (Amano et al., 2000); mouse laminin 
 
g
 
3 short arm (AF079520),
nucleotides 1–3,122; and mouse laminin 
 
b
 
2 short arm (NM_008483), nu-
cleotides 174–3,659. The following full lengths or fragments of the netrin
coding sequences were similarly obtained: mouse netrin-1 (U65418), nu-
cleotides 46–1,812; mouse 
 
b
 
-netrin (AF278532), nucleotides 311–2,143;
and mouse 
 
b
 
-netrin–
 
D
 
C (AF278532), nucleotides 311–1,672. 1 
 
m
 
g of the
total RNA from whole mouse embryo (day 17) was reverse transcribed,
and the PCR was performed following the manufacturer’s instructions
(
 
Pfu Turbo DNA polymerase; Stratagene). The PCR product was purified
on an agarose gel (QIAGEN) and subcloned (rapid DNA ligation kit;
Roche Diagnostics GmbH) into a modified PCEP-4 (gift from Ernst Poe-
schl, Munich, Germany) expression vector. For convenience, a six histi-
dine tag followed by a stop codon was introduced at the 39 end of the lami-
nin g2 and g3 chains sequences adjacent to the BamHI site of the PCEP-4
vector, and a six histidine tag followed by a thrombin cleavage site was in-
cluded adjacent to the NheI site of the b-netrin, netrin-1, and laminin b2
chain sequences. The ligated DNA was transformed into TOP 10 cells (In-
vitrogen). Plasmids were isolated from bacteria (QIAGEN) and se-
quenced with gene-specific primers (Thermo Sequenase cycle sequencing
kit; Amersham Pharmacia Biotech). In the case of the netrin-1 clone, we
detected a single amino acid substitution V to L at position nucleotides
295–297 (present in all the sequenced clones, each of which were indepen-
dent PCR products). 293-EBNA cells (Invitrogen) were transformed (Fu-
Gene; Roche Diagnostics GmbH) with the expression vector and selected
after 2 d with puromycin (Sigma-Aldrich).
Stably transfected 293-EBNA cells were subcloned and the highest pro-
tein producing clones were expanded for large-scale production. 2 liters of
supernatant from these cells was collected and supplemented with 0.5 mM
PMSF. After ammonium sulfate precipitation (45%), the precipitate was
collected by centrifugation and dialyzed against the binding buffer (200
mM NaCl and 20 mM Tris-HCl, pH 8). The dialyzed protein was applied
onto a nickel-chelated Sepharose column (Amersham Pharmacia Biotech)
and washed and eluted with binding buffer containing increasing concen-
trations of imidazole (10–80 mM imidazole). In some cases, the histidine
tag was digested with thrombin (isolated from bovine plasma; Sigma-
Aldrich) according to the protocol from Novagen Inc. The digested pro-
tein was again applied to a nickel-chelated Sepharose column and eluted
with increasing imidazole concentration. The protein was dialyzed against
PBS and the protein concentration was determined according to the proto-
col from Whitaker and Granum (1980). Rotary shadowing was performed
using our previously published methods (Rousselle et al., 1997).
Antibody Production
The b-netrin fusion protein rb-N was injected intradermally into a rabbit
(R33) and mice for antibody production following standard procedures
(Harlow and Lane, 1988). The R33 antiserum was purified over a protein
G column (Amersham Pharmacia Biotech) and eluted with triethylamine
(Sigma Chemical Co.). The neutralized eluate was affinity-purified by ap-
plying it to a mouse b-netrin fusion protein column. To prepare this col-
umn, full-length recombinant b-netrin, from which the His tag was re-
moved, was coupled to activated CNBr-Sepharose. Bound antibodies
were eluted with triethylamine and immediately neutralized. From the hy-
bridoma screen, two positive clones producing mAbs against b-netrin
were identified: 9F11, which our studies show is conformation-sensitive
(data not shown), and 61.
Immunohistochemistry and In Situ Hybridization
Mice and rats were killed according to protocols approved by institutional
animal care committees. Immunohistochemistry was performed as previ-
ously described (Libby et al., 1997; Koch et al., 1999). Adult tissues were
embedded in OCT compound (Miles, Elkhart, IN) and frozen by immer-
sion in liquid nitrogen–cooled isopentane; transverse, 10-mm-thick sec-
tions were cut with a Leica cryostat and placed onto Superfrost Plus slides
(Fisher Scientific Co.). Slides were stored at 220 or 2808C until use. For
use, slides were returned to room temperature, immersed briefly in ace-
tone at 2208C, washed in PBS (137 mM NaCl, 2.68 mM KCl, 10 mM
Na2HPO4, and 1.76 mM KH2PO4, pH 7.4), and incubated in primary anti-
body for 2 h at room temperature or overnight at 48C. Primary antibodies
were diluted in PBS containing 2% goat serum, or 2% BSA, or both. Sec-
tions were washed in PBS containing 0.05% Tween 20 and incubated in
species-appropriate, affinity-purified, fluorescently labeled secondary an-
tibodies diluted in 2% goat serum in PBS for 1 h at room temperature. Af-
ter washes in PBS-Tween 20, stained slides were mounted in fluoromount-G
(Southern Biotechnology Associates, Inc.) or in Prolong (Molecular
Probes, Inc.) to reduce photobleaching.
In situ hybridization was performed as previously described (Libby et
al., 1997) using cRNA probes generated from mouse b-netrin cDNAs, a
mouse netrin-1 cDNA (isolated in our laboratory by PCR), and a mouse
wnt-1 cDNA (obtained from B. Morgan, Harvard University, Cambridge,
MA). cDNA templates were synthesized by PCR (mouse E17 cDNA).
The reverse primer T7 polymerase recognition site sequence (TCCTAC-
GACTCACTATAGGGAGG) was added to the 39 end of the following
probes: for mouse netrin-1 (U65418), probe 1, nucleotides 267–764, and
probe 2, nucleotides 1,213–1,708; for mouse b-netrin (AF281278) probe 1,
nucleotides 340–826, probe 2, nucleotides 1,060–1,509, and probe 3, nucle-
otides 1,406–2,041. Slides were examined and photographed with a Spot
digital camera (Diagnostic Instruments). Images shown here were created
using Adobe Photoshop (Releases 4.0–5.5); no enhancements other than
contrast and brightness have been made to these images.
In Vitro Olfactory Bulb Neurite Outgrowth Assays
Timed pregnant Sprague-Dawley rats were killed according to protocols
approved by institutional animal care committees. E15 embryos were col-
lected and olfactory bulbs were removed into culture medium (DME
[Bio-Whittaker] containing 10%FBS [Hyclone Laboratories Inc.], 100 U/ml
penicillin, and 100 mg/ml streptomycin [both from Irvine Scientific]) es-
sentially as described elsewhere (Pini, 1993; Li et al., 1999). Olfactory
bulbs were divided into three to six explants. At least two, but not more
than four, explants were placed in a drop of 2.4 mg/ml collagen (Vitrogen;
Cohesion Technologies), and the collagen drops were placed in a humidi-
fied 378C incubator (5% CO2) for 45 min to gel. 500 ml of culture medium
or culture medium containing laminin or b-netrin proteins was added to
each collagen drop. Explants were cultured at 378C for 16–24 h and fixed
in 4% paraformaldehyde (Polysciences) in PBS for 5 min at ambient tem-
perature and processed for immunohistochemistry as previously described
(Murrell and Hunter, 1999), using an antiserum against neural cell adhe-
sion molecule (Chemicon International, Inc.), and a rhodamine-conju-
gated secondary antibody (Sigma-Aldrich) diluted in PBS containing 2%
BSA (Sigma-Aldrich), and 0.01% Triton X-100 (Sigma-Aldrich).
Each explant was photographed digitally in multiple fields; the images
were combined to create a composite containing the entire explant and all
neurites. Neurite number and length, explant circumference and explant
area were quantified by tracing from the composites using Scion Image
(Release Beta 3b; Scion Corporation). Measurements for explants within
each collagen gel were averaged, normalized to the control values for a
particular culture, and plotted using Microsoft Excel 97 SR-2. Data are
displayed as the percent control 6 SEM. The statistical significance of dif-
ferences between any two conditions was analyzed using the t test; proba-
bility values of , 0.05 were judged significant.
Other Methods
SDS-PAGE (Laemmli, 1970) and electrophoretic transfer of proteins to
nitrocellulose with immunoblot analysis were performed essentially as de-
scribed elsewhere (Lunstrum, et al., 1986). For chemiluminescence, pri-
mary as well as secondary antibodies (Amersham Life Science) were di-
luted 1:4,000 in 3% milk powder, PBS, and 0.5% Tween 20. For detection,
the Renaissance solution from NEN Life Science Products was used ac-
cording to the manufacturer’s instructions. For the FISH analysis, a 1.7-
kbp PCR product (nucleotides 1,114–2,946) was used for the fluorescent
in situ localization of the b-netrin gene (SeeDNA Biotech, Inc.)
Results
A novel partial cDNA sequence was identified in the
dbEST sequence database by searching for sequences con-
taining laminin EGF-like repeats. A 344-bp sequence was
obtained and this sequence was extended using rapid am-The Journal of Cell Biology, Volume 151, 2000 224
plification of cDNA ends, resulting in the full-length human
cDNA. The mouse cDNA was obtained using nested PCR
with human primers at low annealing temperature, and a
nearly full-length sequence (lacking most of the 39-UTR)
was obtained. The cDNA contains a predicted open read-
ing frame of 629 amino acids, including a 19–amino acid–
long putative signal peptide that closely meets the criteria
described by Nielsen et al. (1997) (Fig. 1). The predicted
protein is a putative secreted molecule with an NH2-termi-
nal domain similar to domain VI of the laminin b chains,
which is a central domain containing EGF-like repeats sim-
ilar to domain V of the laminin b chains, and a COOH-ter-
minal domain homologous to the netrin C domains. The
predicted human and mouse amino acid sequences contain
90% identical laminin VI domains, 91% identical laminin V
domains, and 86% identical C domains. There are two con-
sensus glycosylation sites: one in the VI domain and one in
the C domain; both are present in mouse and human.
Thus, the overall structure of this novel molecule is similar
to the family known as netrins. Three vertebrate netrins (ne-
trins 1–3) have been described in the literature (see Intro-
duction). All contain domains with homology to the laminin
g chain domains V and VI and a COOH-terminal domain.
The b-netrin V and VI domains are 43% identical to the
laminin b1 chain V and VI domains, 42% identical to those
in the laminin b2 chain, and 38% identical to those in the
laminin b3 chain (Fig. 2). The V and VI domains of b-netrin
are 32% identical to those in the laminin g1 chain; for
comparison, netrin-1 has 50% identity with the laminin g1
chain. Full-length mouse b-netrin is 31% identical to mouse
netrin-1 and 28% identical to mouse netrin 3. Among all
the netrins, the second EGF-like repeat is the most highly
conserved (b-netrin versus netrin-1, 54% amino acid iden-
tity; b-netrin versus netrin 3, 56% identity); the EGF-like
repeats 1 and 3 ranged from 26 to 39% amino acid identity.
Recombinant Expression of b-netrin
Full-length recombinant mouse b-netrin (rb-N) including
a His tag and thrombin cleavage site (rb-N 1 His) was ex-
pressed using a mammalian expression vector in 293-
EBNA cells. A shortened form of b-netrin lacking the C
domain (rb-NDC), and full-length recombinant mouse ne-
trin-1 (rN1) were similarly produced. The expressed prod-
ucts were purified using a Ni-containing column, and the
His tag was removed in some cases by thrombin cleavage.
Visualization of rb-N by transmission electron micros-
copy after rotary shadowing indicates that the recombinant
molecule is folded into structures resembling images of
portions of laminin short arms. The globular VI domain at
the NH2 terminus measures z8 nm in diameter and the
short rod contributed by the EGF-like repeats and the C
domain measures z8.6 nm, giving an overall length of z17
nm. Unexpectedly, the best interpretation of 44% of the
images is that the molecules can associate to form dimers,
and, to a lesser extent (1.5%; n 5 788), higher order assem-
blies (Fig. 3 A; a single representative field is shown; a por-
tion of the field is shown at higher magnification in Fig. 3
B). The overall length of the dimer averages 24.6 nm, of
Figure 1. Comparison of the predicted full-length amino acid
sequences of human (h) and mouse (m) b-netrin. Amino acids in
the human sequence that are conserved in mouse are indicated
by dashes. A 19–amino acid signal sequence precedes the b-netrin
NH2 terminus; an arrowhead marks the signal peptide cleavage
site. The predicted amino acid sequence of b-netrin contains
three domains (large boxes): an NH2-terminal domain with ho-
mology to domain VI of laminin b chains, a domain with homol-
ogy to the V domain of laminin b chains, and a COOH-terminal
domain with homology to the C domain of netrins. Potential gly-
cosylation sites are doubly underlined; all are conserved between
human and mouse. EMBL/Genbank/DDBJ accession numbers
for the sequences reported here are as follows: mouse b-netrin,
AF281278; human b-netrin, AF278532.
Figure 2. Genetic relation-
ship of the netrins with the
NH2-terminal regions of se-
lected laminin chains in
mouse. Netrin-1 and -3 are
closely related to the laminin
g chains, whereas b-netrin
shares greater amino acid
identity with the laminin b
chains.Koch et al. b-Netrin: A Novel Netrin 225
which the two VI domains contribute 16 nm, leaving the VI
domains separated by z8.6 nm. Therefore, the images are
consistent with dimerization occurring through antiparallel
linear alignment of the V and C domains (cartoons of the
proposed structures are illustrated next to Fig. 3, B and D).
On the other hand, in rotary shadowed preparations of rb-
NDC, most molecules appear to be monomeric globules
with a short rodlike projection (Fig. 3 C, a single represen-
tative field is shown; a portion of the field is shown at a
higher magnification in Fig. 3 D); the only other form ob-
served in preparations of the rb-NDC are multimeric aggre-
gates, which we interpret as artefacts of the preparation.
The calculated mass of rb-N 1 His is 68 kD; it migrates
with an electrophoretic mobility predicting a final mass of
70 kD (Fig. 4 A). rb-NDC 1 His has an electrophoretic
mobility consistent with a mass of 56 kD (Fig. 4 A), which
corresponds well with a predicted mass of 53 kD. Removal
of the His tag by thrombin cleavage reduces the apparent
molecular mass slightly, as expected. rb-N 1 His and rb-
NDC 1 His, as well as recombinant laminin b2 short arm
containing a His tag are all recognized by an anti-His anti-
body, but there is no residual activity against rb-N after re-
moval of the His tag (Fig. 4 B).
Production and Characterization of Polyclonal and 
Monoclonal Antibodies to b-Netrin
Rabbits and mice were immunized with rb-N 1 His. The
rabbit antiserum was purified using protein G to obtain IgG,
and the isolated antibodies were affinity-purified by column
affinity chromatography using CNBr-activated Sepharose
with attached rb-NDC, from which the His tag had been re-
moved by thrombin cleavage. The product of this protocol is
Figure 3. Transmission electron microscopic images of rb-N and
rb-NDC obtained following rotary shadowing. Representative
fields are shown. 44% of the images of full-length b-netrin (A and
B) appear as dimers, whereas most of those of b-netrin lacking the
C domain (rb-NDC) appear as monomers (C and D). The dimers
appear to associate through an interaction of the V and C domains.
The measured average sizes of the images of the dimers are shown
in the models adjacent to B and D (n 5 30 monomers; 30 dimers).
Figure 4. Electrophoretic profiles of b-netrin expression prod-
ucts and Western analysis using antibodies mAb61, mAb9F11,
and pAbR33. (A) Comparison of the electrophoretic mobilities
of purified full-length recombinant mouse b-netrin including the
His tag (rb-N1His), full-length b-netrin with the His tag re-
moved (rb-N), truncated b-netrin including the His tag (rb-
NDC1His), and recombinant human laminin b2 chain domains
III–VI including the His tag (rb2 1His). Mr, relative molecular
mass standards. Proteins were visualized with Coomassie brilliant
blue R-250. (B) Western blots of recombinant proteins using an
anti-His antibody. Aliquots of culture media from 293-EBNA
cells expressing full-length or truncated b-netrin were electro-
phoretically separated and His-containing proteins were detected
using an anti-His antibody. Despite the fact that the netrins are
minor components of the applied media, only single bands were
detected in the positions expected for full-length or truncated
b-netrin. Purified full-length b-netrin is detected only before re-
moval of the His tag, indicating that this tag is fully eliminated by
cleavage. Purified recombinant laminin b2 chain short arm is
present at sufficient concentration to be easily detected by West-
ern blot. The nomenclature for the individual recombinant pro-
teins is as in A. (C) Characterization of anti-b-netrin antibodies
by Western analysis of recombinant proteins. Three membrane
blots identical to that described in B were probed with the anti-
bodies mAb61, mAb9F11, and pAbR33. The patterns obtained
using all three antibodies is identical: all recognize both the full-
length and truncated forms of b-netrin, indicating that the
epitopes recognized by the mAbs are within domains V or VI,
and the polyclonal antiserum also recognizes epitopes within the
same domain. None of the antibodies cross-reacts with the lami-
nin b2 chain short arm, nor with its His tag. The nomenclature
for the individual recombinant proteins is as in A.The Journal of Cell Biology, Volume 151, 2000 226
termed pAbR33. Hybridomas were produced from mouse
splenic lymphocytes, and clones 9F11 and 61 were deter-
mined to react with rb-N and with rb-NDC by ELISA (data
not shown) and by Western blot analysis.
All three antibody preparations, pAbR33, mAb9F11,
and mAb61, react identically by Western blot analysis.
Specifically, all three react with a single band in the super-
natants from cultured 293-EBNA cells expressing either
rb-N 1 His or rb-NDC 1 His. Coomassie blue staining of
these culture supernatants shows multiple bands with the
same or greater intensity than seen for the expression
product (not shown). The identified bands have electro-
phoretic mobilities identical to rb-N 1 His or rb-NDC 1
His (Fig. 4 C). Removal of the His tag has no effect upon
the antibodies ability to recognize either recombinant pro-
tein (Fig. 4 C). Thus, all three antibody preparations
clearly recognize epitopes in domains V and VI of the
molecule. None of the antibodies reacts with the recombi-
nant laminin b2 short arm, which includes the His tag, by
Western analysis (Fig. 4 C).
Given the high amino acid identity among the laminins
and in the netrins in the V and VI domains, we compared
the reactivity of our antibody preparations to known ex-
pression patterns of laminin chains. Although all of the an-
tibodies are useful in immunohistochemistry (see below),
none reacts with the basement membrane at the dermal–
Figure 5. b-Netrin RNA is ex-
pressed widely in human and mouse
tissues. The same cDNA probe was
used to probe adult human tissue
blots (A) and a dot blot (B). Only a
single major RNA species is de-
tected on the tissue blots. Strong
signals are present in spleen, pros-
tate, ovary, heart, kidney and pan-
creas, mammary gland, and uterus.
Only weak signals are present in
brain tissue. (C) RT-PCR confirms
strong expression of b-netrin RNA
in adult mouse kidney, heart, and
ovary, as expected from the human
blot analyses. In addition, b-netrin
RNA is readily detected in several
CNS structures including, olfactory
bulb and retina. Some expression is
observed in other brain regions;
however, spinal cord, brain stem,
and dorsal root ganglia contain only
low levels of b-netrin RNA.Koch et al. b-Netrin: A Novel Netrin 227
epidermal junction of skin by immunohistochemistry (data
not shown). Therefore, none of these antibodies cross-
reacts with the laminin b1, b3, g1, or g2 chains. The distri-
bution of b-netrin in the retina is also different than the
distribution of either the laminin b2 or g3 chain (data not
shown); therefore, we conclude our antibodies are not
cross-reacting with these laminin chains.
The monoclonal anti–rb-N antibody, 9F11, recognizes a
conformation-specific epitope. No reactivity of 9F11 is ob-
served after the disulfide bond reduction of the electro-
phoretic sample (data not shown). The b-netrin species
identified by 9F11 in Fig. 4 C was not reduced, whereas
those identified with the monoclonal 61 or pAbR33 were
disulfide bond–reduced products. The species identified
by all the antibodies in Fig. 4 C have the same electro-
phoretic mobilities, indicating that the molecules are not
associated into disulfide-bonded aggregates. These data
indicate that the b-netrin dimers visualized by rotary shad-
owing are not stabilized covalently.
Tissue Distribution of b-Netrin RNA
RNA expression analysis (Fig. 5, A and B) of b-netrin in
human tissues showed that b-netrin is most highly ex-
pressed in kidney, spleen, mammary gland, aorta, heart,
ovary, prostate, and fetal spleen. Next, we performed semi-
quantitative RT-PCR on various mouse tissues and con-
firmed that, as in humans, b-netrin expression is high in kid-
neys, hearts, and ovaries (Fig. 5 C). However, we obtained
signals from neural tissues as well (Fig. 5 C). A strong signal
was obtained from the whole brain (not shown) and retina;
fractionation of the whole brain into component regions
(Fig. 5 C) demonstrates a low level of expression in most re-
gions, with the exception of the olfactory bulb, where the
signal strength approached those obtained from the kidney,
heart, and ovary. Below, we have focused our histological
studies on those tissues in which PCR signals were high; our
studies of the retina will be reported elsewhere.
Comparison of the Tissue Distribution of b-Netrin 
RNA and b-Netrin Protein
Tissue distribution of the b-netrin protein was determined
by indirect immunofluorescence in various rat tissues and
the cellular sources of b-netrin were determined by in situ
hybridization. One immediately obvious generalization is
that b-netrin is expressed in the basement membranes of a
variety of tissues (see Figs. 6–9). In the kidney (Fig. 6),
b-netrin protein is expressed in the basement membranes
of all tubules. The major arteries and arterioles (Fig. 6 A,
arrows) were prominently reactive; also strongly reactive
were the afferent arterioles (Fig. 6, C and D). Particularly
clear was the reactivity in the basal lamina surrounding the
smooth muscle cells in the wall of the vessels. In addition,
b-netrin immunoreactivity was present in the basement
membrane of the rat glomerulus. This pattern of immu-
noreactivity is different than that reported for the laminin
b2 chain (Hunter et al., 1989), further supporting a lack of
cross-reactivity between these molecules. b-Netrin tran-
scripts, as judged by in situ hybridization, are localized to
all cells in the kidney (Fig. 6 E), including the tubular epi-
thelial, vascular endothelial, mesangial, and Bowman’s
capsule cells; an equally well labeled probe with a similar
G-C content showed no hybridization (Fig. 6 F). These ob-
Figure 6. b-Netrin is expressed and deposited in basement membranes throughout the adult rat kidney. b-Netrin was detected by indi-
rect immunofluorescence using three different anti–b-netrin antibodies (indicated). b-Netrin immunoreactivity can be observed within the
major and minor arteries (arrows in A), and in the afferent arterioles (B–D). All portions of the tubules are recognized by the antibodies
(A–C), as is the mesangium of the glomeruli (B–D). In situ localization of b-netrin RNA shows reaction product deposited throughout the
kidney (D; control probe shown in E), consistent with the protein localization. Bars: (A) 100 mm; (B, C, E and F) 50 mm; (D) 25 mM.The Journal of Cell Biology, Volume 151, 2000 228
servations suggest that b-netrin is a prominent element of
the basement membrane and that both the epithelium and
the mesenchyme contribute to its production.
As the RNA expression (Fig. 5) suggested high levels of
b-netrin expression in the ovary, we examined the distri-
bution of b-netrin in the female reproductive system. Tis-
sue distribution of b-netrin in the ovary and the fallopian
tube showed analogous distribution. For example, b-netrin
immunoreactivity was a prominent element of the base-
ment membrane of the fallopian tube (Fig. 7 A) and the
arterial smooth muscle in the lamina propria (Fig. 7 A). In
addition to the basal reactivity, there is some b-netrin im-
munoreactivity at the apical surface of the epithelium, sug-
gesting the fallopian epithelium is at least one source of
the molecule. In situ hybridization confirms this sugges-
tion, and demonstrates that b-netrin transcripts are local-
ized to the apical and basal ends of the fallopian epithe-
lium (data not shown).
The ovary expresses b-netrin as well; in this tissue, in
contrast to both the kidney and the fallopian tube, there is
a developmentally regulated appearance of b-netrin. Spe-
cifically, b-netrin immunoreactivity is observed only in the
basement membrane of the secondary or mature follicles
(Fig. 7 C); primary follicles are not reactive (Fig. 7, B and
D). Dense alkaline phosphate reaction product localizing
RNA transcripts for b-netrin are observed in the large ma-
turing follicles, whereas the primary follicles are more
lightly labeled (Fig. 7 B). Control sections with a similarly
well-labeled probe do not label the ovary (data not shown).
Immunoreactivity was also present in the perimysium of
the heart (Fig. 7 E), where b-netrin is expressed surround-
ing individual muscle cells; in situ hybridization localizes
transcripts to the cardiac wall and the aorta during embry-
onic development, E15.5 (Fig. 7 F). We also examined the
spleen; our analysis was complicated by high background
binding of secondary antibodies to splenocytes, but b-netrin
is prominently expressed in this tissue (not shown, but see
RNA expression in Fig. 5). There appeared to be more re-
activity in red pulp than in white.
As netrin-1 and netrin-2 are classically described as neu-
ral guidance molecules produced by the floorplate; we in-
vestigated whether b-netrin was expressed in the develop-
ing spinal cord along with netrins 1 and 2. We looked at
E11.5 to E17.5 mouse embryos and found only diffuse im-
munoreactivity, which we could not distinguish from con-
trol sections (data not shown). Next, we turned to in situ
hybridization using tissue from E11.5, E15, and E17 em-
bryos. We compared the b-netrin expression pattern to
that of the two other developmentally regulated molecules,
netrin-1, which is expressed by the floorplate, and wnt1,
which is expressed by the roofplate. In situ hybridizations
confirm the expression of both of these molecules at E11.5.
Netrin-1 is expressed at high levels in the floorplate (Fig. 8
A); expression levels are above background in the ventric-
ular epithelium to the midpoint of the dorsal-ventral axis.
Expression of wnt1, on the other hand, is confined to a
small number of cells in the roofplate (Fig. 8 B). None of
the three cRNA probes (generated to different regions of
the b-netrin RNA) showed convincing levels of expression
in the cord or in the dorsal root ganglion (two probes are
shown in Fig. 8, C and D) at this age or earlier ages.
We also examined the adult brain, focusing on the area
in which our RT-PCR results suggested there was high ex-
pression. In contrast to the brilliant staining of peripheral
basement membranes, b-netrin expression in the brain
was more difficult to interpret until we focused on selected
regions of the brain in which RT-PCR showed high levels
of expression. For example, in the olfactory bulb, we ob-
served a clear expression pattern. In situ hybridization
confirmed the presence of b-netrin transcripts within the
olfactory bulb (Fig. 9 A); specifically, in the periglomeru-
lar cells and the lateral olfactory tract; in addition, the ven-
tricular epithelium showed considerable binding of the
b-netrin antisense probes and some expression was de-
tected in the mitral cell layer. Immunohistochemistry dem-
onstrated b-netrin immunoreactivity within the lateral ol-
Figure 7. b-Netrin is expressed and deposited in the basement
membranes of the adult rat fallopian tube and ovary. (A) R33 an-
tiserum shows b-netrin deposition in the basement membranes
underlying the fallopian epithelium, and the arterial smooth mus-
cle in the underlying lamina propria. Some reactivity also appears
at the epithelial apical surface. (B) In situ hybridization in the
ovary demonstrating that secondary follicles have a high level of
expression of b-netrin transcripts. Surrounding primary follicles
are less well labeled. The scale here is twice C. (C) b-Netrin is ex-
pressed and deposited in the basement membranes of the adult
rat ovary. With the R33 antiserum, a strong signal is observed in
the basement membrane of the secondary follicles, as well as sur-
rounding arterial smooth muscle. The marker is 100 mm. (D)
Higher power view of the in situ hybridization in maturing folli-
cles; high levels of expression of b-netrin transcripts are observed
in the perifollicular cells. Primary follicles, which surround the
maturing ones, are less well labeled. The scale is as in B. (E)
b-netrin immunoreactivity in the adult heart. Immunoreactivity
is concentrated in the interstitial spaces surrounding cardiac myo-
cytes. The scale is one quarter that of F. (F) In situ hybridization
in fetal heart shows prominent labeling in the ventricular muscle
wall as well as very high levels of expression in the smooth mus-
cle of the aorta and pulmonary vessels. Bar, 100 mm (in F).Koch et al. b-Netrin: A Novel Netrin 229
factory tract (Fig. 9 B) as well as in the perineurium of the
vomeronasal nerve (Fig. 9 C); only a weak, diffuse immu-
noreactivity was observed in the glomeruli of the olfactory
bulb. Finally, there was strong deposition of b-netrin im-
munoreactivity in the basement membranes of the vascu-
lar supply of the brain as well as in capillary beds (Fig. 9, B
and C). We observed this reactivity throughout the brain.
We also detected in situ hybridization signals in vascular
endothelial cells and the choroid plexus at embryonic ages
(E15.5; data not shown).
Effects of b-Netrin on Neurite Outgrowth
Because of the similarity in structure of b-netrin to netrins
1–3, and because b-netrin expression was detected in the
output pathways of the olfactory bulb and the retina, we
tested the ability of b-netrin to promote neurite out-
growth. Explants of E15 rat olfactory bulb were dissected,
embedded in collagen gels, and incubated with soluble re-
combinant full-length and truncated b-netrin (rb-N and
rb-NDC; Fig. 10). In control cultures, neurites extend
around the circumference of the explant (Fig. 10 A).
Treatment with rb-netrin increases both the neurite length
and the number of neurites extending from cultures (Fig.
10, B and C). We measured several parameters of this in-
crease in neurite outgrowth including the following: total
number of neurites; average neurite length; total length of
Figure 8. b-Netrin RNA ap-
pears not to be expressed in
the floorplate of midgestation
mouse embryos. (A and B)
nonradioactive in situ hybrid-
izations of floor- and roof-
plate markers (netrin-1, and
wnt-1) show good localization
of transcriptions to these struc-
tures, respectively. (C and D)
Two different probes for
b-netrin, on the other hand,
fail to localize to any region in
embryonic day 11.5 spinal cord;
in D we see some above back-
ground reactivity in the lateral
margins of the floorplate.
Figure 9. b-Netrin is expressed in the adult rat olfactory bulb.
(A) Heavy in situ reaction product is observed over the lateral ol-
factory tract, the output pathway from the bulb (arrowhead, Lat
Olf Tract); in the periglomular cells (arrowhead, Glom L); and in
mitral cell layer, the projection neurons of the bulb. Some reac-
tion product is observed in the ventricles, ependyma and perhaps
the blood vessel epithelium. (B and C) Protein localization by in-
direct immunofluorescence shows immunoreactivity in the lateral
olfactory tract and the perineurum of the vomeronasal nerve
(V-Nn). In addition, considerable immunoreactivity is observed
in the basement membrane of the blood vessels.The Journal of Cell Biology, Volume 151, 2000 230
neurites (sum neurite length); and total neurite area (Ta-
ble I). By all measures, the addition of rb-N produced an
increase in neurite outgrowth; these data are shown graph-
ically in Fig. 10. With the addition of rb-N, there was a
dose-dependent increase in both the sum length of all neu-
rites and the number of neurites (normalized to explant
circumference) of up to 400% of control measurements
(Fig. 10, D and E, rb-N); values in the presence of all but
the lowest concentration of rb-N were statistically differ-
ent from control values (P , 0.05). The addition of an af-
finity-purified preparation of pooled anti–b-netrin anti-
sera antagonized this effect, reducing neurite length and
number to control levels.
The addition of the truncated version of b-netrin miss-
ing the C domain, rb-NDC, to explants also increased the
total neurite length and the number of neurites extending
from the explants (Fig. 10, D and E, b-NDC). However,
with increased concentrations of the truncated form of the
molecule, the neurite length and number returned to con-
trol levels; biphasic responses to netrin application are
well documented in the literature (Serafini et al., 1994).
We also tested the effect of homologous regions of laminin
chains on this system: we tested expressed short arm frag-
ments of both laminin g2 and g3 chains as well as similar
fragments of the laminin b2 chain. The addition of recom-
binant fragments of the laminin g2 or g3 chains increased
neurite extension, measured either as sum length or num-
ber of neurites (Fig. 10, D and E, g2 SA and g3 SA) but
both g chain short arms were slightly less effective at stim-
ulating outgrowth than b-netrin. Interestingly, increasing
the dose of the added laminin g chain short arms had de-
creased efficacy on neurite stimulation, which is similar to
that observed with rb-NDC. On the other hand, the short
arm fragment of the laminin b2 chain had no statistically
significant effect on neurite extension over the concentra-
tion range we tested (Fig. 10, D and E, b2 SA).
Chromosomal Localization
Using FISH, the gene encoding b-netrin was localized to
human chromosome12, region q22-q23 (not shown). Near
this site are several genes associated with human ovarian
cancer. b-Netrin cDNA sequences have been identified in
the dbEST databases derived from ovarian and cervical
cancers, and multiple sclerosis.
Discussion
The Netrins Are a Family of Laminin-like Molecules
The netrins now define a family of molecules related to the
NH2 termini of laminin chains (Fig. 11). Netrins 1–3 all are
more related to the laminin g chain than they are to other
laminin chains, whereas the molecule reported here, b-netrin,
is structurally related to the laminin b chains. However, it
must be noted that Unc-6 (netrin-1) retains hallmarks of
both b and g chain specifically in the second EGF repeat
(Wadsworth et al., 1996), where there is considerable ho-
mology among the netrins and laminins (see above).
Given that there are three laminin chain isoforms (a, b,
and g), there are likely to be additional members of the ne-
trin family, as there have been no laminin a chain netrin
analogues reported as yet. Indeed, we have identified two
additional netrinlike molecules (Fig. 11); one of these has a
putative transmembrane domain. These molecules have
laminin-like domains VI and V resembling the laminin
short arm. However, these molecules do not have the C
domain present in the known netrins and, thus, are likely
to form a novel subfamily. The complete identification of
these molecules will be reported elsewhere. However,
their existence suggests that a large family of laminin short-
arm–related molecules exist and that they are broadly dis-
tributed and may have diverse functions beyond the oft-
studied axonal guidance properties of the netrins.
Figure 10. b-Netrin produces neurite outgrowth from olfactory
bulb explants. (A–C) Representative cultures treated as indicated.
Treatment with rbNDC or full-length rbN proteins increases the
number of neurites produced by the explants. (D) Quantification of
data obtained on neurite outgrowth; the total length of all neurites
produced by explants is given here (Sum Length). Protein additions
are noted below the bars; the line indicates that cultures were
treated identically; the concentrations of protein additions are noted
below the line. b-Netrin conventions are as above; 14 nM 1 AB in-
dicates the simultaneous addition of 14 nM bN and pooled poly-
clonal antisera to bN. g2SA denotes the short arm of the laminin g2
chain; similar conventions are used for g3 and b2 chains. * Statisti-
cally significant difference versus control; # statistically significant
difference versus 14 nM bN or 9 nM g3SA, respectively; P , 0.05.Koch et al. b-Netrin: A Novel Netrin 231
Structurally, b-netrin is similar in most respects to the
other members of the netrin family. Our observation that
b-netrin can form dimers, however, was unexpected, as
such data has not been reported to our knowledge for the
other members of the family. The rotary-shadowed images
are most consistent with dimerization occurring via inter-
actions in the C domain of one molecule with the V do-
main of its partner, as the VI domains are separated by the
approximate length of one, but not two, V and C domains.
If b-netrin dimerizes in vivo, this could have implications
for signal transduction. For example, dimers could cluster
b-netrin receptors on individual cells, or it could bridge
two cells expressing b-netrin receptors. Indeed, the dimer-
ization of netrin receptors is a critical feature of netrin sig-
naling, as the heterodimerization of the Unc5h2 and DCC
netrin receptors is necessary and sufficient to convert ne-
trin attraction to repulsion (Hong et al., 1999); however,
receptor dimerization occurs even with monomeric ligand
(Hong et al., 1999). Some caution must be used until the
biologically active sites are defined as dimerization may in
fact reduce activity (see below) and the availability of ef-
fector binding sites.
Of the previously reported netrins, only two (netrins 1
and 3) have been identified in the mouse (Puschel, 1999;
Wang et al., 1999); netrin-2 has not. Is b-netrin the mam-
malian equivalent of netrin-2? This is unlikely, as netrin-2,
like netrins-1 and -3, is more closely related to the laminin
g chains, whereas b-netrin is a laminin b chain homologue.
Moreover, the distribution of b-netrin is unlike that of the
previously described netrins. Although much of the work
on netrins 1 and 2 has focused on the role of these mole-
cules in neural development, they are widely expressed
outside the nervous system. This new member of the fam-
ily is expressed primarily outside the nervous system, most
abundantly in the vasculature, kidney, ovary, and the
heart. Netrin-3 is highly expressed in somatic tissues, par-
ticularly in the lungs and heart (Puschel, 1999; Wang et al.,
1999). The function of the netrins outside the nervous sys-
tem has not been well studied.
Within the nervous system, the expression of b-netrin is
limited largely to the retina and olfactory bulb. In our
hands,  b-netrin is not expressed in the spinal cord or in the
dorsal root ganglion, unlike netrins 1–3. Our in situ results
and immunohistochemical localization failed to demon-
strate any b-netrin in the floorplate or DRG during devel-
opment and in adult tissue. b-Netrin is expressed within
the CNS vasculature, both in large muscular arteries as
well as small capillaries, and in the ventricular ependymal
Table I. Outgrowth from Olfactory Bulb Explants
Percent of control
 No. of experiments  No. of explants  Sum neurite length  Average neurite length Neurite area Neurites per circumference  No. of neurites
Control 24 52 100 6 14 100 6 4 100 6 10 100 6 11 100 6 11
rb-netrin
 7  nM 6 11 127  6  31 109  6  7 143  6  23 108  6  28 131  6 25
 14  nM 20 41 246  6  32* 139  6  11* 160  6  8* 188  6  18* 189  6 17*
 28 nM 10 16 368 6 39* 154 6 10* 197 6 25* 265 6 26* 265 6 17*
  14 nM 1 Ab 6 12 108 6 18‡ 121 6 15 112 6 18‡ 90 6 15‡ 100 6 13‡
rb-netrin DC
 19  nM 4 8 587  6  63* 168  6  11* 235  6  18* 344  6  68* 370  6 48*
 38  nM 4 8 355  6  91* 135  6  16 136  6  26 285  6  70* 279  6 46*
190 nM 5 15 65 6 10  85  6  18  64 6 18 84 6 9 78 6 11
rg2
 15  nM 10 20 217  6  50* 113  6  9 136  6  25 178  6  23* 185  6 29*
 30  nM 9 24 225  6  60 130  6  18 139  6  26 151  6  24 166  6 27
 60 nM 3 8 82 6 48 106 6 15  65 6 31 68 6 27§  91  6 53
rg3
 9  nM 10 23 215  6  45* 122  6 14 146 6 26 172 6 28* 177 6 28*
 18  nM 10 23 139  6  27 102  6 5   96  6  13 117  6  18 140  6 24
  36 nM 2 7 47 6 19 150 6 65   49 6 31§ 58 6 0§ 42 6 32§
rb2
  8 nM 3 8 65 6 14  70  6 6*  51  6 8*  99  6 22 89 6 19
 16  nM 6 23 124  6  12 103  6 12 107 6 26 132 6 34 123 6 31
 32  nM 3 10 188  6  77 128  6 16§ 192 6 81 164 6 58 166 6 43
*P , 0.05 versus control.
‡P , 0.05 versus 7 nM rb-netrin.
§P , 0.05 versus 15 nM rg2, 9 nM rg3, or 8 nM rb2.
Figure 11. Cartoon of lami-
nin and netrin families.
Three classes of netrin mole-
cules have been described;
netrins 1–3 are more related
to laminin g chains, whereas
the netrin reported here,
b-netrin, is more related to
the laminin b chains. Two
additional molecules, one of
which is a putative trans-
membrane molecule and are
homologous to the short arm
of laminin chains, have been
found (see text for details;
for simplicity they are shown
along side the a chain). Thus,
there is a growing family of
molecules which have ho-
mology to the short arms of
laminin molecules.The Journal of Cell Biology, Volume 151, 2000 232
cells. Thus, b-netrin could have an important role in CNS
angiogenesis; indeed, its expression outside the nervous
system in somatic vasculature supports this suggestion.
b-Netrin Is a Basement Membrane Molecule
Unlike investigations of netrins-1 and -3, which have
largely relied on RNA expression and predicted the pro-
tein localization from those data, we have produced three
antibody preparations that reliably detect b-netrin on both
blots and tissue sections and have demonstrated where
b-netrin protein is deposited. Befitting its origin as a lami-
nin-like molecule, b-netrin is deposited in the basement
membranes of a variety of tissues, most prominently the
kidney, ovary, heart and vasculature. While the location of
a netrin in these regions may be surprising to some, it is
not without precedent, as the localization of netrin-1 to the
perimeter of the spinal cord in the region of the pia, a
basement membrane-like structure in the CNS, has been
reported in the chicken (MacLennan et al., 1997) and Unc-6
is considered part of the body wall basement membrane
(Hedgecock et al., 1990; Wadsworth et al., 1996). These
observations are seemingly at odds with the diffusible
chemotropic hypothesis of netrin action. Specifically,
b-netrin is deposited in close apposition to the source of
synthesis. For example, b-netrin RNA is expressed in the
tubules of the kidney and the epithelium of the fallopian
tube; b-netrin protein is deposited in the subjacent base-
ment membranes. In situ hybridization on large blood ves-
sels shows that the b-netrin message is localized to the
smooth muscle wall of the vessels, as is b-netrin protein
(Figs. 6, 7, and 9). We have confirmed smooth muscle as
one source of this molecule by isolating the protein from
supernatants of primary cultures of smooth muscle cells
(data not shown); however, we cannot exclude the endo-
thelium as another source.
The colocalization of b-netrin RNA expression and pro-
tein deposition is less consistent with the chemoattractive
or chemorepulsive mechanisms that have been suggested
for the other netrins. Gradients of protein expression have
been postulated for these molecules (Kennedy et al., 1994;
Serafini et al., 1994). In the case of netrin-1 such a gradient
may exist across the spinal cord, as there is a point source
for netrin-1 in the floorplate and the netrin-1 protein ap-
pears to be localized to the perimeter of the spinal cord
and the adjoining pial basement membrane. Thus, given a
source (floorplate) and an apparent sink (in the pial base-
ment membrane), there may be a gradient, the grade of
which will be determined by the turnover of the molecule
at both source and sink. In contrast, in the CNS, b-netrin
RNA and b-netrin protein are present in immediately ad-
jacent structures. For example, RNA transcripts are ob-
served in the lateral olfactory tract and protein is de-
posited there. Thus, there does not appear to be the
possibility of a gradient of b-netrin expression, unless it is
a very steep one. However, caution should be used in in-
terpreting these data, as a demonstration of developmen-
tal gradients of soluble signaling molecules is difficult and
our antibodies may only detect the sinks for b-netrin
where its concentration will be the highest.
Nonetheless, b-netrin may be important in axon guid-
ance or pathfinding in the CNS. Disruptions of basement
membranes, netrins, ECM elements, and their receptors
produce a wide variety of disruptions in axon guidance
and neuronal migration (Przyborski et al., 1998; Deiner
and Sretavan, 1999; Yee et al., 1999; Alcantara et al., 2000;
Goldowitz et al., 2000; Walsh and Goffinet, 2000). These
processes, although conceptually different, may differ for-
mally only by the translocation, or lack thereof, of the cell
body. One neuroactive component of the epidermal base-
ment membrane in C. elegans is Unc-6 itself (Hedgecock
et al., 1990; Ishii et al., 1992); indeed, HA-tagged Unc-6
molecules are secreted and incorporated into the matrix
around secreting cells, seemingly assembling into the base-
ment membrane (Wadsworth et al., 1996), suggesting that
this basement membrane can act as a repository for neural
guidance molecules. Other components of the basement
membrane can also affect pathfinding; for example, muta-
tions in C. elegans that disrupt the expression of the base-
ment membrane component, nidogen, do not disrupt for-
mation of the basement membrane per se but do produce
defects in axonal migration (Kim and Wadsworth, 2000);
specifically, axons that are normally laterally directed are
redirected to the midline, and there are pathfinding de-
fects in other identified axons as they cross the midline.
Thus, the authors suggest that the body wall contains spe-
cialized subsets of basement membranes, which are impor-
tant cues for guiding circumferential versus longitudinal
migrations. Therefore, basement membrane components
participate directly in determining the pathways of subsets
of axons. b-Netrin may be another basement membrane
component that provides such guidance cues. Functional
disruptions of b-netrin using genetic systems or other ap-
proaches will resolve this speculation.
b-Netrin Affects Neurite Outgrowth
An initial step in defining the developmental role of b-netrin
was taken in this study. The localization of b-netrin within
the lateral olfactory tract, and the well-documented ability
of netrins to direct neurite outgrowth, prompted us to de-
termine if b-netrin supported neurite extension. Indeed,
the addition of purified b-netrin to our culture system pro-
moted neurite elongation. Specifically, the parameter
most affected was apparently the initiation of elongation,
which is the number of neurites produced, in contrast to
any measure of length of neurites (Table I).
This finding suggests that b-netrin is a permissive signal
and stimulates neurite elongation. Coupled with the ex-
pression data, it suggests that b-netrin acts by stabilizing
the extending axons in some way. Since outgrowth fre-
quently occurs by the overgrowth of pioneering axons by
secondary axons, perhaps b-netrin is stabilizing the con-
tacts between these jointly growing neurites, contributing
to fasciculation. Indeed, b-netrin immunoreactivity is as-
sociated with the basal laminae in the perineurium of both
the vomeronasal nerve (Fig. 9) and the optic nerve (data
not shown). Alternatively, the incorporation of b-netrin
into these basement membranes may contribute an inhibi-
tory boundary function to these structures similar to what
has been proposed for netrin-1, which is localized in the
perimeter of the spinal cord (MacLennan et al., 1997).
However, the stimulatory effect we see upon axon out-
growth from olfactory bulb explants argues against this
possibility and suggests that b-netrin may be functioning
in a fashion similar to netrin-1 which is expressed alongKoch et al. b-Netrin: A Novel Netrin 233
the optic pathway (Deiner and Sretavan, 1999) and disrup-
tions of which disrupt ganglion cell routing (Deiner et al.,
1997). However, it should be noted that netrins stimulate
axonal elongation and cell migration in some systems and
inhibit them in others (Serafini et al., 1994; Colamarino
and Tessier-Lavigne, 1995; Wadsworth et al., 1996; Kim et
al., 1999; Alcantara et al., 2000). Thus, the apparent stimu-
latory effect of b-netrin on olfactory bulb neurites should
not be generalized to other axons. Moreover the mecha-
nisms of action of b-netrin on individual olfactory bulb
and retinal neurites await single cell assays (de la Torre et
al., 1997; Hong et al., 1999).
It is somewhat perplexing to find that b-netrin and the
short arm domains of the laminin g2 and g3 chains all have
similar effects upon axon outgrowth from olfactory bulb
explants in vitro. The positive effects of the g2 short arms
are particularly informative, as g2 totally lacks the VI do-
main and contains only three and one-half EGF-like re-
peats in domain V. Thus, the g2 chain and b-netrin share
amino acid identity in only the second and third EGF-like
repeats of laminin domain V. These findings strongly sug-
gest that the outgrowth activity of b-netrin and laminins
themselves may be mediated by EGF-like repeats within
the V domain. In fact, the EGF-like repeat, V-2, is the
most highly conserved among the mouse netrins, suggest-
ing that the outgrowth-promoting activity may reside
within this region of the molecule. Others have made simi-
lar suggestions in C. elegans (Wadsworth et al., 1996) and
have shown that the Unc 6 molecule contains multifunc-
tional guidance cues; the V-2 domain is important in axon
guidance, specifically repelling circumferential axons dor-
sally. Moreover, the COOH-terminal region is not neces-
sary to rescue the netrin-1 deletion (Lim et al., 1999). The
only data that appear to conflict with this model are those
provided by the laminin b2 short arm. It is interesting that,
although the b2 short arm is the fragment with greatest
identity to b-netrin, the b2 short arm has no statistically
significant effect on neurite extension or elongation, in
contrast to other laminin short arms. This is despite a
slight trend towards increased neuritogenesis in treated
cultures (Fig. 10 and Table I).
Two final points deserve attention. First, all species of
molecules applied in our assay inhibited neurite extension
if applied at a high concentration. This suggests that the
response of neurons to laminin short arms and the netrins
is biphasic; similar data have been reported for netrin-1
(Serafini et al., 1994; Métin et al., 1997). The biphasic re-
sponse may reflect multiple receptors for these molecules
or multiple signal transduction cascade mechanisms. Re-
sponses to netrin-1 are complex and can be repulsive as
well as attractant for both axons and migrating neurons
(Serafini et al., 1994; Colamarino and Tessier-Lavigne,
1995; Wadsworth et al., 1996; Kim et al., 1999; Alcantara et
al., 2000). Second, it is worthy to note that b-netrin lacking
the C domain has a greater activity in our neurite exten-
sion assay on a molar basis than does full-length b-netrin
(Table I). This may reflect the observation that full-length,
but not truncated b-netrin forms dimers (Fig. 3). In this
assay, dimer formation may reduce the apparent activity
of b-netrin; further experiments are needed to determine
the mechanisms of action of b-netrin. In C. elegans, while
a truncated form of the netrin-1 molecule (unc6DC) can
rescue the UNC6(2/2) phenotype, it produces aberrant
branching (Lim et al., 1999) which might be related to in-
creased activity of truncated form of b-netrin that we have
observed in vitro.
b-Netrin May Have Significant Roles Outside of the 
Central Nervous System
In addition to its expression in the nervous system,
b-netrin is deposited around the smooth muscle cells of all
somatic muscular arteries, between cardiac myocytes and
in the basement membrane of brain capillaries. Together,
these data suggest a role for b-netrin in vascular develop-
ment. Several recent studies document that some molecu-
lar species are active in both nervous and vascular devel-
opment. For example, neuropilin-1, which is a critical axon
guidance molecule, has been shown to be a receptor for
vascular endothelial growth factor and to be expressed by
endothelial cells (Soker et al., 1998). Mice deficient in neu-
ropilin-1 expression demonstrate vascular insufficiency
and disorganization. Similarly, the putative neural guid-
ance molecules, the ephs and ephrins, are expressed in the
vascular system; ephrin-B2 has been found on the surfaces
of arteries but not on veins (Wang et al., 1998) and a com-
plementary expression of its receptor eph-B4 was found
on veins but not arteries. These findings support the con-
cept that these neuroactive signaling molecules may be
crucial for morphogenesis of the vascular tree. Finally,
neural stem cells, presumably fated to generate neurons,
are also capable of taking on a smooth muscle cell fate un-
der certain conditions (Tsai and McKay, 2000).
Similarly, it may be that b-netrin functions in both the
nervous system and in the vasculature. In both systems,
the protein product is present near its site of synthesis,
suggesting that in both systems b-netrin is not instructive
in either axonal guidance or vascular development but
may be permissive, promoting axonal or vascular develop-
ment. Whereas the functions and mechanisms of action of
b-netrin await elucidation, its localization in basement
membranes suggests b-netrin may stabilize growing and
mature elements, or provide positive growth cues along es-
tablished axon or vascular highways.
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